Anaplastic lymphoma kinase inhibitors as anticancer therapeutics: a patent review
Author:
Publisher
Informa Healthcare
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543776.2014.877890
Reference62 articles.
1. Anaplastic lymphoma kinase proteins in growth control and cancer
2. Cell Signaling by Receptor Tyrosine Kinases
3. Anaplastic Lymphoma Kinase Is Required for Neurogenesis in the Developing Central Nervous System of Zebrafish
4. Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
5. The anaplastic lymphoma kinase in the pathogenesis of cancer
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparative Atomistic Insights on Apo and ATP-I1171N/S/T in Nonsmall-Cell Lung Cancer;ACS Omega;2023-11-06
2. A Review on Indole as a Cardinal Scaffold for Anticancer Drugs Development;Current Cancer Therapy Reviews;2023-10-10
3. Recent Updates on Structural Aspects of ALK Inhibitors as an Anticancer Agent;Anti-Cancer Agents in Medicinal Chemistry;2023-05
4. An updated patent review of anaplastic lymphoma kinase inhibitors (2018–2022);Expert Opinion on Therapeutic Patents;2023-04-03
5. Inflammatory myofibroblastic tumour of the common bile duct: a case report and literature review;World Journal of Surgical Oncology;2023-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3